Chemotherapy-induced nausea and vomiting (CINV) has a significant impact on quality of life and is a dreaded adverse effect of cancer treatment. As the understanding of the underlying pathophysiology of this process has evolved, so has treatment. There are numerous effective options for preventing both acute and delayed CINV. Following the evidence-based guidelines will significantly reduce the incidence of this feared adverse effect.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of Managed Care Medicine|
|State||Published - 2014|
ASJC Scopus subject areas
- Health Policy